127 related articles for article (PubMed ID: 9398022)
1. Predicting the risk of tumor recurrence following transplantation for hepatocellular carcinoma.
Marsh JW; Casavilla A; Iwatsuki S; Dvorchik I; Subotin M; Balan V; Rakela J; Subbotin V; Popechitelev EP
Hepatology; 1997 Dec; 26(6):1689-91. PubMed ID: 9398022
[No Abstract] [Full Text] [Related]
2. Albumin mRNA in plasma predicts post-transplant recurrence of patients with hepatocellular carcinoma.
Cheung ST; Fan ST; Lee YT; Chow JP; Ng IO; Fong DY; Lo CM
Transplantation; 2008 Jan; 85(1):81-7. PubMed ID: 18192916
[TBL] [Abstract][Full Text] [Related]
3. Unusual presentation of recurrent hepatocellular carcinoma as obstructive jaundice 15 years after liver transplant.
Camci C; Gurakar A; Kohli V; Sharma S; Jabbour N
Exp Clin Transplant; 2007 Dec; 5(2):713-5. PubMed ID: 18194129
[TBL] [Abstract][Full Text] [Related]
4. Selection criteria for patients with hepatocellular carcinoma in liver transplantation.
Kaido T; Takada Y; Uemoto S
Transplantation; 2009 Aug; 88(3):442-3; author reply 443. PubMed ID: 19667951
[No Abstract] [Full Text] [Related]
5. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.
Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Kim IH; Yi NJ; Lee KU
Surgery; 2007 May; 141(5):598-609. PubMed ID: 17462459
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma.
Reddy MS; Manas DM
Transplantation; 2007 Feb; 83(3):367-8. PubMed ID: 17297420
[No Abstract] [Full Text] [Related]
7. Molecular tools and hepatocellular carcinoma: Adding help or confusion in liver transplantation?
Vibert E; Samuel D
J Hepatol; 2008 Oct; 49(4):498-501. PubMed ID: 18678433
[No Abstract] [Full Text] [Related]
8. Quantitative analysis of factors in recurrence of hepatocellular carcinoma.
Kanno T; Harihara S; Kinoshita H; Tamori A; Kim K; Kuroki T; Mizoguchi Y; Kobayashi K; Hirohashi K; Monna T
Osaka City Med J; 1987 Dec; 33(2):121-35. PubMed ID: 2840621
[No Abstract] [Full Text] [Related]
9. Hilar lymph nodes sampling at the time of liver transplantation for hepatocellular carcinoma: to do or not to do? Meta-analysis to determine the impact of hilar lymph nodes metastases on tumor recurrence and survival in patients with hepatocellular carcinoma undergoing liver transplantation.
Sotiropoulos GC; Malagó M; Molmenti EP; Lösch C; Lang H; Frilling A; Broelsch CE; Neuhäuser M
Transpl Int; 2007 Feb; 20(2):141-6. PubMed ID: 17239022
[TBL] [Abstract][Full Text] [Related]
10. Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators.
Zimmerman MA; Ghobrial RM; Tong MJ; Hiatt JR; Cameron AM; Hong J; Busuttil RW
Arch Surg; 2008 Feb; 143(2):182-8; discussion 188. PubMed ID: 18283144
[TBL] [Abstract][Full Text] [Related]
11. Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study.
Ikoma J; Kaito M; Ishihara T; Nakagawa N; Kamei A; Fujita N; Iwasa M; Tamaki S; Watanabe S; Adachi Y
Hepatogastroenterology; 2002; 49(43):235-8. PubMed ID: 11941963
[TBL] [Abstract][Full Text] [Related]
12. Are the Hangzhou criteria adaptable to hepatocellular carcinoma patients for liver transplantation in Western countries?
Audet M; Panaro F; Piardi T; Wolf P
Liver Transpl; 2009 Jul; 15(7):822-3; author reply 824-6. PubMed ID: 19562722
[No Abstract] [Full Text] [Related]
13. Molecular markers and hepatocellular carcinoma: lending a helping hand in liver transplantation?
Dai Z; Yu L; Zhou J; Qiu SJ; Fan J
Expert Rev Gastroenterol Hepatol; 2009 Jun; 3(3):211-3. PubMed ID: 19485802
[No Abstract] [Full Text] [Related]
14. Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival.
Marsh JW; Finkelstein SD; Demetris AJ; Swalsky PA; Sasatomi E; Bandos A; Subotin M; Dvorchik I
Liver Transpl; 2003 Jul; 9(7):664-71. PubMed ID: 12827550
[TBL] [Abstract][Full Text] [Related]
15. Tumor size remains key for prediction of hepatocellular carcinoma recurrence after liver transplantation.
Earl TM; Chapman WC
Ann Surg Oncol; 2011 May; 18(5):1217-8. PubMed ID: 21327456
[No Abstract] [Full Text] [Related]
16. Hepatoma-related gamma-glutamyl transferase in laboratory or clinical diagnosis of hepatocellular carcinoma.
Yao DF; Dong ZZ
Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):9-11. PubMed ID: 17287158
[No Abstract] [Full Text] [Related]
17. Predictors and patterns of recurrence after resection of hepatocellular carcinoma.
Cha C; Fong Y; Jarnagin WR; Blumgart LH; DeMatteo RP
J Am Coll Surg; 2003 Nov; 197(5):753-8. PubMed ID: 14585409
[TBL] [Abstract][Full Text] [Related]
18. [Scrutiny and management of a patient with hepatocarcinoma].
Mondragón Sánchez R; Echeverría Miranda CA; Gómez Gómez E
Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():69-70. PubMed ID: 17471865
[No Abstract] [Full Text] [Related]
19. Liver transplantation in patients with hepatocellular carcinoma.
Schwartz M
Liver Transpl; 2004 Feb; 10(2 Suppl 1):S81-5. PubMed ID: 14762845
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of prognosis and recurrence of hepatocellular carcinoma treated from 1988 to 2002 at Department of Medicine III, Kyushu University Hospital].
Arimura E; Nakamuta M; Kotoh K; Morizono S; Fukutomi M; Ohta S; Enjoji M; Sakai H; Nawata H
Fukuoka Igaku Zasshi; 2004 Aug; 95(8):195-200. PubMed ID: 15552961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
